In mice, stress altered the way that the brain formed memories, resulting in an unnecessary fear response. Neurotransmitters in the amygdala might be why we have anxious responses in harmless situations.Credit: Owen Franken/Corbis via Getty Stress makes mice form big bundles of neurons in the brain that disrupt memory formation, making them fearful of harmless...
Author: admin
Post
11 Medications You Should Take on an Empty Stomach
Written by Kristianne Hannemann, PharmD | Reviewed by Austin Ulrich, PharmD, BCACP Updated on April 15, 2024print_outlinedemail_outlined Key takeaways: Table of contents Definition Thyroid medications Bisphosphonates Sucralfate Slidenafil Rybelsus Captopril Bethanechol Ampicillin Zafirlukast PPIs Isoniazid Bottom line References fotostorm/E+ via Getty Images If you’ve ever been told to take medication on an empty stomach, you might still have...
Post
Oakland clinic gets medical device maker to disclose risk of false blood-oxygen reading
by Corinne Purtill, Los Angeles Times Credit: Pixabay/CC0 Public Domain The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of health care’s most fundamental tools. So when Dr. Noha Aboelata learned that research stretching back decades showed that the devices routinely failed patients with...
Post
Study shows potential of optogenetics in treating epilepsy
by University of California, San Francisco HD-MEA recordings of human hippocampal slices. Credit: Nature Neuroscience (2024). DOI: 10.1038/s41593-024-01782-5 In what could one day become a new treatment for epilepsy, researchers at UC San Francisco, UC Santa Cruz and UC Berkeley have used pulses of light to prevent seizure-like activity in neurons.The study appears Nov. 15 in Nature Neuroscience. The...
Post
FDA approves Cobenfy for adults with schizophrenia
by Lori Solomon The U.S. Food and Drug Administration has approved Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults. The oral medication represents the first new class of medicine in several decades and selectively targets M1 and M4 receptors in the brain, without blocking D2 receptors. The approval is...
Post
SCIENCE & TECHNOLOGY NEWS
Flower power: Researchers coax bacteria-eating viruses into floral shapes that boost antimicrobial strength A group of McMaster researchers who routinely work with bacteriophages — viruses that eat bacteria — had a pleasant and potentially very important surprise while preparing slides to view under a powerful microscope. Virus – illustrative photo. Image credit: Pixabay (Free Pixabay license) After treating samples...
Post
Diabetes medication shows promise in reducing alcohol use
University of NottinghamNov 15 2024 New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use. The study, which is published in eClinicalMedicine, looked at whether a type of diabetes medication, called GLP-1 receptor agonists (GLP-1 RAs), could also...
Post
Without immediate action, nearly 260 million people in the US predicted to be overweight or obese by 2050
by Lancet Credit: Unsplash/CC0 Public Domain Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least doubling in adult men and women (aged 25 and older) and older female and male adolescents (aged 15–24 years) since 1990, with the number of people living with overweight...
Post
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
by Elana Gotkine For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according to a study scheduled for presentation at the annual meeting of the American Society of Hematology, to be held from Dec. 7 to 10 in San...
Post
AI tool predicts cancer gene activity from biopsy images
by Sarah C.P. Williams, Stanford University Medical Center A new AI program, SEQUOIA, can analyze a microscopy image from a tumor biopsy (left, purple) and rapidly determine what genes are likely turned on and off in the cells it contains (gene expression shown in shades of red and blue on right). Credit: Emily Moskal/Stanford Medicine To...